Abstract
Introduction:
Diabetes mellitus (DM) has been a global public health concern for decades contributing to increasing morbidity and mortality. The glucocentric approach of management has been effective yet inadequate in achieving glycemic control and preventing complications. This called for a continuous glucose monitoring (CGM) system where the approach is patient-centric and the study was thus undertaken to explore and understand the impact of CGMS in the management of DM.
Materials and methods:
A quasi-experimental study was conducted among patients diagnosed and under treatment for DM where their clinical profile and self-monitoring of blood glucose (SMBG) levels were recorded. Two CGMS sensors—Freestyle Libre Pro (FSLP) and Freestyle Libre (FSL) were used to record their glycemic profile for a duration of 15 days each. FSLP recorded their initial profile based on which diet and lifestyle modifications were advised by healthcare providers (HCP), followed by the use of FSL.
Results:
Forty patients were enrolled for the study where 53% belonged to the age group of 50-69 years and 65% were males. More than 50% patients had DM for more than 10 years and 77.5% patients had higher HbA1c levels (6.1%–10%). The CGMS sensors showed that their overall glycemic profile was improved including their average blood glucose and HbA1c which were 33.12 and 1.12 times lower in FSL recording than FSLP (before intervention), respectively.
Conclusion:
Given the dynamics associated with glucose in diabetes, and the inadequacy of SMBG to predict all the variations, upgrading to the CGMS approach has proven to be more clinically valuable in attaining the Time-in-Range (TIR) target and improving the patient’s quality of life.
Keywords
Get full access to this article
View all access options for this article.